AMR Logo.png
Biosimilars Market is Projected to Reach an Estimate of $143.6 Billion by 2031, with CAGR of 24.7% : Allied Market Research 
October 26, 2023 07:35 ET | Allied Market Research
Wilmington, Delaware, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Allied Market Research released a report, titled, “Biosimilars Market by Type (Erythropoietin, Human growth hormone, Monoclonal antibodies,...
Global Erythropoietin Drugs Market
Global Erythropoietin (EPO) Drugs Market Analysis Report 2023-2031: Rising Prevalence of CKD, Growing Use in Oncology, Drug Delivery Advancements, & Biosimilars and Patent Expirations, Key to Growth
September 04, 2023 05:37 ET | Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Erythropoietin Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. In the dynamic...
Global Erythropoietin Drugs Market
Global Erythropoietin (EPO) Drugs Market Analysis Report 2023-2031: Rising Prevalence of CKD, Growing Use in Oncology, Drug Delivery Advancements, & Biosimilars and Patent Expirations, Key to Growth
September 04, 2023 05:34 ET | Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Erythropoietin Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. In the dynamic...
Global Erythropoietin Drugs Market
Global Erythropoietin Drugs Market Report 2023: Sector is Expected to Reach $7.8 Billion by 2030 at a CAGR of 1.5%
May 15, 2023 11:33 ET | Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Erythropoietin Drugs Market Size, Share & Trends Analysis Report By Type (Biologics, Biosimilars) By Product (Erythropoietin, Darbepoetin-alfa), By...
pegylated-proteins-market-size.jpg
Global PEGylated Proteins Market Analysis & Industry Trends Report 2022: A $2.1 Billion Market by 2028 - Focus on Colony-stimulating Factor, Interferons, Recombinant Factor VII, & Erythropoietin
March 22, 2023 10:13 ET | Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Global PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type (Colony-stimulating Factor,...
Global Erythropoietin Drugs Market
Insights on the Erythropoietin Drugs Global Market to 2027 - by Drug Class, Product Type, Application, End-user and Region
January 17, 2023 05:08 ET | Research and Markets
Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "Erythropoietin Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Next Move Strategy Consulting.png
Global Biopharmaceutical Market to Generate USD 974.48 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
August 02, 2022 06:41 ET | Next Move Strategy Consulting
New York, Aug. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global biopharmaceutical market generated USD 345.84 billion in 2021, and is...
AMR Logo.png
Global Downstream Processing Market is Expected to Reach $92.0 Billion by 2030: Says AMR
July 07, 2022 20:00 ET | Allied Market Research
Portland, OR, July 07, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Downstream Processing Market was estimated at $21.8 billion in 2020 and is...
22157.jpg
Global $3.11 Bn Erythropoietin (EPO) Markets, 2015-2020, 2020-2025F, 2030F Featuring Amgen, Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion, and LG Life Sciences
December 21, 2021 05:53 ET | Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global $20+ Billion Erythropoietin Drugs Market to 2027
July 07, 2021 05:48 ET | Research and Markets
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Global Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027"...